News and Breakthroughs
Read the latest news from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University. The links below take you to articles where you can learn more about our center's latest events and accomplishments. You can also visit the article archive for older news. Visit our Photo Gallery to view photos and videos from various events
When Candace Henley was diagnosed with colorectal cancer in 2003, she was a 35-year-old single mother raising five daughters. As a Black woman, she found herself feeling as though she was falling through the cracks in the healthcare system.
Seema Khan, MD, and Yuan Luo, PhD, presented their research on “Computational Phenotyping to Ascertain Breast Cancer Recurrence,” by framing their lecture with a problem; the lack of accessible or existing data about breast cancer recurrence.
Award recipients are nominated by their colleagues and teammates for their skill, medical knowledge, and for going above and beyond expectations to provide exceptional and compassionate cancer care.
Perioperative chemotherapy treatment did not improve overall survival for patients with resectable pancreatic cancer, according to a recent Northwestern Medicine clinical trial.
Blocking the arginine methylation pathway, which helps brain tumor cells proliferate by promoting cell division, could improve cancer therapies, according to a recent study.
Capability could accelerate the development of new treatments for diseases
Northwestern Medicine investigators have identified a protein kinase called DYRK1A and its downstream substrates as potential therapeutic targets for treating pediatric patients with B-cell acute lymphoblastic leukemia.
Through the unwavering dedication of our extraordinary clinicians, scientists, and staff we were able to respond rapidly and thoughtfully — providing our patients with the highest level of care in the safest possible environment while protecting the health of our community.
A new antibody drug demonstrated similar efficacy to currently available therapies to treat advanced ERBB2-positive breast cancer, according to a recent clinical trial.
T-cell acute lymphoblastic leukemia hijacks a signaling pathway to produce nucleotides, a basic building block of life that fuels the growth and spread of the cancer, according to a recent study.
Northwestern Medicine scientists have detailed the diverse function of CDK9-containing complexes and their impact on gene expression in a recent study published in the journal Genes and Development.
A new Northwestern Medicine study has discovered why Black men die more often of prostate cancer yet also have greater survival benefits from immunotherapy treatments.
Northwestern Medicine investigators have identified a potential combined targeted therapy approach for treating glioblastoma, according to a recent study published in the journal Scientific Reports.
The FDA has approved a new HER2-targeted therapy for the treatment of metastatic breast cancer based on findings from a pivotal clinical trial published in JAMA Oncology.
- Lurie Cancer Center Joins Leading Cancer Organizations to Warn Cancer Doesn’t Stop for COVID-19 and Neither Should You01.28.2021
Lurie Cancer Center is teaming up with the National Comprehensive Cancer Network® (NCCN®), the American Cancer Society (ACS) and other leading cancer organizations across the country to endorse the resumption of cancer screening and treatment during the ongoing COVID-19 pandemic.
Formerly ignored ‘genetic junk’ plays critical role in skin cell differentiation and regeneration
Physician-scientist Melissa Simon wants to make health care work for everyone.
A team led by Northwestern Medicine investigators has identified a novel molecular target that may improve the efficacy of current treatments for triple-negative breast cancer.
- Seth Pollack, MD, Joins Northwestern Medicine as Director of the Sarcoma Program of the Lurie Cancer Center01.06.2021
Seth Pollack, MD, a leading expert on immunotherapy strategies for treating sarcomas, has joined the Robert H. Lurie Comprehensive Cancer Center of Northwestern University as Medical Director of the Sarcoma Program. He is also the Steven T. Rosen, MD, Professor of Cancer Biology and associate professor of Medicine in the Division of Hematology and Oncology at the Feinberg School of Medicine.
Take a look back at a handful of groundbreaking research discoveries that marked one of, if not the most, unprecedented and transformative years for Feinberg.
See more news in the article archive.